• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Biogen Inc

    Recent news which mentions Biogen Inc

    < Previous 1 2 3 4 Next >
    Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
    Tags Health & Science GSK plc AstraZeneca PLC
    From CNBC.com News
    Biogen beats estimates on cost cuts and new drugs like Leqembi, but profit outlook falls short
    Tags Biotech and Pharmaceuticals US: News Breaking News: Earnings
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Prices 5 Things to Know Investment strategy
    From CNBC.com News
    Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
    Tags Biogen Inc US: News LILLY DRN
    From CNBC.com News
    Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
    Tags Health care industry Eisai Co Ltd Pharmaceuticals
    From CNBC.com News
    Wednesday's big stock stories: What’s likely to move the market in the next trading session
    Tags stocks GSK plc Lennar Corp
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Pfizer Inc Ford Motor Co Bristol/Myers Squibb Co
    From CNBC.com News
    Thursday's big stock stories: What's likely to move the market in the next trading session
    Tags Lockheed Martin Corp Pentair PLC PRO: Playbooks
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Ford Motor Co Markets Investing
    From CNBC.com News
    Alzheimer's drug Leqembi promises to give patients more time, but they face a long road to treatment
    Tags Business News Biotechnology Breaking News: Business
    From CNBC.com News
    Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
    Tags Earnings Business News Biotechnology
    From CNBC.com News
    Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
    Tags Business Health & Science Biotech and Pharmaceuticals
    From CNBC.com News
    Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
    Tags Biotech and Pharmaceuticals Breaking news Science
    From CNBC.com News
    European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
    Tags Biogen Inc US: News Business News
    From CNBC.com News
    Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
    Tags Stock Picks Investment strategy Investment Strategy
    From CNBC.com News
    Cramer's Lightning Round: Bank of America is a buy
    Tags Business News Fidelis Insurance Holdings Ltd Chevron Corp
    From CNBC.com News
    Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
    Tags Business Health & Science Biotech and Pharmaceuticals
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Microsoft Corp Hasbro Inc Tesla Inc
    From CNBC.com News
    Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
    Tags Pharmaceuticals Companies Health care industry
    From CNBC.com News
    Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
    Tags Biogen Inc Biotech and Pharmaceuticals Healthy Returns
    From CNBC.com News
    Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
    Tags Earnings Business News Biotechnology
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Airbnb Inc DoorDash Inc Tesla Inc
    From CNBC.com News
    Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
    Tags Social issues Health & Science Business
    From CNBC.com News
    Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
    Tags Novo Nordisk A/S Biotech and Pharmaceuticals Health & Science
    From CNBC.com News
    5 things to know before the stock market opens Monday
    Tags Politics Economy Lyft Inc
    From CNBC.com News
    More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
    Tags Health & Science Business Breaking news
    From CNBC.com News
    Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
    Tags Depression Business Health & Science
    From CNBC.com News
    Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
    Tags Enphase Energy Inc Reata Pharmaceuticals Inc Mondelez International Inc
    From CNBC.com News
    Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
    Tags Breaking News: Markets Alaska Air Group Inc MSCI Inc
    From CNBC.com News
    Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
    Tags Biotech and Pharmaceuticals Health & Science Business
    From CNBC.com News
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.